COMMITMENTS AND CONTINGENCIES (Details) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |
|---|---|---|---|---|
Mar. 31, 2021 |
Dec. 31, 2019 |
Dec. 31, 2020 |
Oct. 12, 2020 |
|
| Fair value as of beginning period | $ 77,858,000 | $ 56,360,000 | ||
| Change in valuation inputs or other assumptions | (17,346,000) | 18,250,000 | 21,498,000 | |
| Fair value as of Ending period | 60,512,000 | 56,360,000 | $ 77,858,000 | |
| Prosus Agreement [Member] | ||||
| Probability for consummation of business combination | 85.00% | 85.00% | ||
| Fair value as of beginning period | 50,481,190 | $ 0 | ||
| Change in valuation inputs or other assumptions | (25,948,777) | (21,488,264) | ||
| Fair value as of Ending period | $ 24,532,413 | $ 0 | $ 50,481,190 |
| X | ||||||||||
- Definition Probability for consummation of business combination. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|